New, long-term insights from the Adenoma Prevention with Celecoxib Trial on a promising but troubled class of drugs.
Dubois
Raymond N
RN
Department of Cancer Biology and Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. rdubois@mdanderson.org